Keyphrases
Circular RNA
100%
Breast Cancer Heterogeneity
100%
New Layers
100%
Non-coding RNA (ncRNA)
42%
Breast Cancer
28%
Anticancer Therapeutics
14%
Therapeutic Regimen
14%
Malignant Transformation
14%
Closed-loop
14%
Epigenetic Regulators
14%
Tissue Expression
14%
RNA Molecules
14%
Technique Analysis
14%
High-throughput Sequencing Technique
14%
Authentic Context
14%
Diagnostic Biomarker
14%
Tumoral
14%
Malignancy
14%
Solid Malignancies
14%
Novel Therapeutic Targets
14%
Transformation Process
14%
Cell Signaling Pathways
14%
Prognostic Biomarker
14%
Development Research
14%
Intratumoral Heterogeneity
14%
Drug Development
14%
Hematological Malignancies
14%
Regulatory Role
14%
Bioinformatics Analysis
14%
Junk RNA
14%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Untranslated RNA
100%
Malignant Transformation
33%
Drug Development
33%
Biological Marker
33%
Biochemistry, Genetics and Molecular Biology
Circular RNA
100%
Non-Coding RNA
50%
Signal Transduction
33%
RNA
33%
Malignant Transformation
16%
High Throughput Sequencing
16%
Anticancer
16%
Epigenetics
16%